SCHEMBL19786358

SCHEMBL19786358

c1ccc(-c2nc(-c3cccc4ccccc34)nc(-n3c4c5ccccc5ccc4c4c5c6ccc7ccccc7c6oc5c5ccccc5c43)n2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.37
KDM4E B2RXH2 5/20 0.37
MAPT P10636 5/20 0.37
HPGD P15428 4/20 0.37
MAPK1 P28482 4/20 0.37
HSD17B10 Q99714 4/20 0.37
TP53 P04637 3/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
TSHR P16473 2/20 0.37
NFKB1 P19838 1/20 0.37
NFKB2 Q00653 1/20 0.37
RELA Q04206 1/20 0.37
ATM Q13315 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
CYP1A1 P04798 8/20 0.33
CYP1A2 P05177 8/20 0.33
CYP1B1 Q16678 8/20 0.33
ABCG2 Q9UNQ0 3/20 0.33
ABCC1 P33527 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19786326 0.91 ALDH1A1 (0.36) ALDH1A1KDM4EMAPTHPGDMAPK1
SCHEMBL19890932 0.84 MAPT (0.37) ALDH1A1KDM4EMAPTHPGDMAPK1
SCHEMBL19786324 0.84 CYP1A1 (0.36) ALDH1A1KDM4EMAPTHPGDMAPK1
SCHEMBL21432048 0.81 KDM4E (0.36) ALDH1A1KDM4EMAPTHPGDMAPK1
SCHEMBL19786556 0.81 CYP1A1 (0.36) ALDH1A1KDM4EMAPTHPGDMAPK1
SCHEMBL25460008 0.80 MAPT (0.49) ALDH1A1KDM4EMAPTHPGDMAPK1
SCHEMBL21432055 0.79 MAPT (0.34) ALDH1A1KDM4EMAPTHPGDMAPK1
SCHEMBL21432038 0.79 BCHE (0.38) ALDH1A1KDM4EMAPTHPGDMAPK1
SCHEMBL25668597 0.78 ALDH1A1 (0.43) ALDH1A1KDM4EMAPTHPGDMAPK1
SCHEMBL29298677 0.78 ALDH1A1 (0.45) ALDH1A1KDM4EMAPTHPGDMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190300535-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2019-10-03 US disclosed
WO-2018012781-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF 덕산네오룩스 주식회사 2018-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190300535-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF ORC3, OR51E2, ORAI2 ALDH1A1 2141/4885KDM4E 442/4885MAPT 610/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.